The PE Ratio as of December 2025 (TTM) for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is 93.97

According to Shenzhen Salubris Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 93.97. This represents a change of 26.37% compared to the average of 74.36 of the last 4 quarters.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Historical PE Ratio (quarterly & annually)

How has 002294.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Shenzhen Salubris Pharmaceuticals Co., Ltd. over the last ten years is 82.94. The current 93.97 PE Ratio has changed 11.23% with respect to the historical average. Over the past ten years (40 quarters), 002294.SZ's PE Ratio was at its highest in in the June 2020 quarter at 170.84. The PE Ratio was at its lowest in in the December 2019 quarter at -3017.92.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shenzhen Salubris Pharmaceuticals Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Average PE Ratio

How has 002294.SZ PE Ratio performed in the past?

The current PE Ratio of Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) PE Ratio vs. Peers

How is 002294.SZ’s PE Ratio compared to its peers?

Shenzhen Salubris Pharmaceuticals Co., Ltd.’s PE Ratio is greater than Huadong Medicine Co., Ltd (19.24), greater than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (-192.84), greater than Imeik Technology Development Co.,Ltd. (29.99), greater than Shanghai Pharmaceuticals Holding Co., Ltd (11.84), less than Haisco Pharmaceutical Group Co., Ltd. (188.65), greater than Zhejiang NHU Company Ltd. (10.40), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (-175.52), greater than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (21.93), greater than Gan & Lee Pharmaceuticals. (43.08), greater than Hangzhou Tigermed Consulting Co., Ltd. (73.20),

Build a custom stock screener for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Salubris Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Salubris Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.